SEARCH

SEARCH BY CITATION

References

  • Aifantis, I., Raetz, E. & Buonamici, S. (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nature Reviews. Immunology, 8, 380390.
  • Amylon, M.D., Shuster, J., Pullen, J., Berard, C., Link, M.P., Wharam, M., Katz, J., Yu, A., Laver, J., Ravindranath, Y., Kurtzberg, J., Desai, S., Camitta, B. & Murphy, S.B. (1999) Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia, 13, 335342.
  • Arico, M., Valsecchi, M.G., Conter, V., Rizzari, C., Pession, A., Messina, C., Barisone, E., Poggi, V., De Rossi, G., Locatelli, F., Micalizzi, M.C., Basso, G. & Masera, G. (2002) Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin–Frankfurt–Muenster protocol II. Blood, 100, 420426.
  • Cheok, M.H. & Evans, W.E. (2006) Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy. Nature Reviews. Cancer, 6, 117129.
  • Clarke, M., Gaynon, P., Hann, I., Harrison, G., Masera, G., Peto, R. & Richards, S., Childhood ALL Collaborative Group. (2003) CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials. Journal of Clinical Oncology, 21, 17981809.
  • Conter, V., Schrappe, M., Aricó, M., Reiter, A., Rizzari, C., Dördelmann, M., Valsecchi, M.G., Zimmermann, M., Ludwig, W.D., Basso, G., Masera, G. & Riehm, H. (1997) Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Journal of Clinical Oncology, 15, 27862791.
  • Gaynon, P.S., Trigg, M.E., Heerema, N.A., Sensel, M.G., Sather, H.N., Hammond, G.D. & Bleyer, W.A. (2000) Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995. Leukemia, 14, 22232233.
  • Goldberg, J.M., Silverman, L.B., Levy, D.E., Dalton, V.K., Gelber, R.D., Lehmann, L., Cohen, H.J., Sallan, S.E. & Asselin, B.L. (2003) Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. Journal of Clinical Oncology, 21, 36163622.
  • Goshen, Y., Stark, B., Kornreich, L., Michowiz, S., Feinmesser, M. & Yaniv, I. (2007) High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer, 49, 294297.
  • Gray, R.J. (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics, 16, 11411154.
  • Griffin, T.C., Shuster, J.J., Buchanan, G.R., Murphy, S.B., Camitta, B.M. & Amylon, M.D. (2000) Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia, 14, 792795.
  • Hijiya, N., Hudson, M.M., Lensing, S., Zacher, M., Onciu, M., Behm, F.G., Razzouk, B.I., Ribeiro, R.C., Rubnitz, J.E., Sandlund, J.T., Rivera, G.K., Evans, W.E., Relling, M.V. & Pui, C.H. (2007) Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. Journal of the American Medical Association, 297, 12071215.
  • Hill, F.G., Richards, S., Gibson, B., Hann, I., Lilleyman, J., Kinsey, S., Mitchell, C., Harrison, C.J. & Eden, O.B., The UK Medical Research Council Working Party on Childhood Leukaemia. (2004) Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). British Journal of Haematology, 124, 3346.
  • Huang, L., Tissing, W.J., De Jonge, R., Van Zelst, B.D. & Pieters, R. (2008) Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia. Leukemia, 22, 17981800.
  • Jankovic, M., Brouwers, P., Valsecchi, M.G., Van Veldhuizen, A., Huisman, J., Kamphuis, R., Kingma, A., Mor, W., Van Dongen-Melman, J. & Ferronato, L. (1994) Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia. ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet, 344, 224227.
  • Jansen, N.C., Kingma, A., Schuitema, A., Bouma, A., Veerman, A.J. & Kamps, W.A. (2008) Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 26, 30253030.
  • Kamps, W.A., Bökkerink, J.P., Hakvoort-Cammel, F.G., Veerman, A.J., Weening, R.S., Van Wering, E.R., Van Weerden, J.F., Hermans, J., Slater, R., Van Den Berg, E., Kroes, W.G. & Van Der Does-van den Berg, A. (2002) BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996). Leukemia, 16, 10991111.
  • Kishi, S., Cheng, C., French, D., Pei, D., Das, S., Cook, E.H., Hijiya, N., Rizzari, C., Rosner, G.L., Frudakis, T., Pui, C.H., Evans, W.E. & Relling, M.V. (2007) Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood, 109, 41514157.
  • Laver, J.H., Barredo, C., Amylon, M., Schwenn, M., Kurtzberg, J., Camitta, B.M., Pullen, J., Link, M.P., Borowitz, M., Ravindranath, Y., Murphy, S.B. & Shuster, J. (2000) Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report. Leukemia, 14, 369373.
  • Löning, L., Zimmermann, M., Reiter, A., Kaatsch, P., Henze, G., Riehm, H. & Schrappe, M. (2000) Secondary neoplasms subsequent to Berlin–Frankfurt–Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood, 95, 27702775.
  • Maloney, K.W., Shuster, J.J., Murphy, S., Pullen, J. & Camitta, B.A. (2000) Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies form 1986–1994. Leukemia, 14, 22762285.
  • Manera, R., Ramirez, I., Mullins, J. & Pinkel, D. (2000) Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype. Leukemia, 14, 13541361.
  • Matloub, Y., Lindemulder, S., Gaynon, P.S., Sather, H., La, M., Broxson, E., Yanofsky, R., Hutchinson, R., Heerema, N.A., Nachman, J., Blake, M., Wells, L.M., Sorrell, A.D., Masterson, M., Kelleher, J.F. & Stork, L.C., Children’s Oncology Group. (2006) Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children’s Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children’s Oncology Group. Blood, 108, 11651173.
  • Mody, R., Li, S., Dover, D.C., Sallan, S., Leisenring, W., Oeffinger, K.C., Yasui, Y., Robison, L.L. & Neglia, J.P. (2008) Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood, 111, 55155523.
  • Moghrabi, A., Levy, D.E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V.K., Lipshultz, S.E., Neuberg, D.S., Gelber, R.D., Cohen, H.J., Sallan, S.E. & Silverman, L.B. (2007) Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 109, 896904.
  • Möricke, A., Reiter, A., Zimmermann, M., Gadner, H., Stanulla, M., Dördelmann, M., Löning, L., Beier, R., Ludwig, W.D., Ratei, R., Harbott, J., Boos, J., Mann, G., Niggli, F., Feldges, A., Henze, G., Welte, K., Beck, J.D., Klingebiel, T., Niemeyer, C., Zintl, F., Bode, U., Urban, C., Wehinger, H., Niethammer, D., Riehm, H. & Schrappe, M., German–Austrian–Swiss ALL-BFM Study Group (2008) Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood, 111, 44774489.
  • Nachman, J., Sather, H.N., Gaynon, P.S., Lukens, J.N., Wolff, L. & Trigg, M.E. (1997) Augmented Berlin–Frankfurt–Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children’s Cancer Group. Journal of Clinical Oncology, 15, 22222230.
  • Nachman, J., Sather, H.N., Cherlow, J.M., Sensel, M.G., Gaynon, P.S., Lukens, J.N., Wolff, L. & Trigg, M.E. (1998) Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children’s Cancer Group. Journal of Clinical Oncology, 15, 920930.
  • Nathan, P.C., Whitcomb, T., Wolters, P.L., Steinberg, S.M., Balis, F.M., Brouwers, P., Hunsberger, S., Feusner, J., Sather, H., Miser, J., Odom, L.F., Poplack, D., Reaman, G. & Bleyer, W.A. (2006) Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children’s Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leukemia & Lymphoma, 47, 24882504.
  • Peterson, C.C., Johnson, C.E., Ramirez, L.Y., Huestis, S., Pai, A.L., Demaree, H.A. & Drotar, D. (2008) A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatric Blood & Cancer, 51, 99104.
  • Pinkel, D. & Woo, S. (1994) Prevention and treatment of meningeal leukemia in children. Blood, 84, 355366.
  • Pui, C.-H.. (2006) Acute lymphoblastic leukemia. In: Childhood Leukemias. (ed. by C.-H.Pui) pp. 439472. Cambridge University Press, New York.
  • Pui, C.-H. & Howard, S.C. (2008) Current management and challenges of malignant disease in the CNS in paediatric leukaemia. The Lancet Oncology, 9, 257268.
  • Pui, C.-H., Sandlund, J.T., Pei, D., Campana, D., Rivera, G.K., Ribeiro, R.C., Rubnitz, J.E., Razzouk, B.I., Howard, S.C., Hudson, M.M., Cheng, C., Kun, L.E., Raimondi, S.C., Behm, F.G., Downing, J.R., Reiling, M.V. & Evans, W.E. (2004) Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children’s Research Hospital. Blood, 104, 26902696.
  • Pui, C.-H., Robison, L.L. & Look, A.T. (2008) Acute lymphoblastic leukaemia. Lancet, 371, 10301043.
  • Pullen, J., Boyett, J., Shuster, J., Crist, W., Land, V., Frankel, L., Iyer, R., Backstrom, L., Van Eys, J., Harris, M., Ravindranath, Y. & Sullivan, M. (1993) Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B-progenitor acute lymphoblastic leukemia: a Pediatric Oncology Group study. Journal of Clinical Oncology, 11, 839849.
  • Pullen, J., Shuster, J.J., Link, M., Borowitz, M., Amylon, M., Carroll, A.J., Land, V., Look, A.T., McIntyre, B. & Camitta, B. (1999) Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia, 13, 16961707.
  • Reddick, W.E., Shan, Z.Y., Glass, J.O., Helton, S., Xiong, X., Wu, S., Bonner, M.J., Howard, S.C., Christensen, R., Khan, R.B., Pui, C.H. & Mulhern, R.K. (2006) Small white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer, 106, 941949.
  • Reiter, A., Schrappe, M., Ludwig, W.D., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Lampert, F., Havers, W., Niethammer, D., Odenwald, E., Ritter, J., Mann, G., Welte, K., Gadner, H. & Riehm, H. (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood, 84, 31223133.
  • Saarinen-Pihkala, U.M., Gustafsson, G., Carlsen, N., Flaegstad, T., Forestier, E., Glomstein, A., Kristinsson, J., Lanning, M., Schroeder, H. & Mellander, L., Nordic Society of Pediatric Hematology Oncology. (2004) Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): nordic results on an intensive regimen with restricted central nervous system irradiation. Pediatric Blood & Cancer, 42, 823.
  • Schrappe, M., Reiter, A., Ludwig, W.D., Harbott, J., Zimmermann, M., Hiddemann, W., Niemeyer, C., Henze, G., Feldges, A., Zintl, F., Kornhuber, B., Ritter, J., Welte, K., Gadner, H. & Riehm, H. (2000a) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German–Austrian–Swiss ALL-BFM Study Group. Blood, 95, 33103322.
  • Schrappe, M., Reiter, A., Zimmermann, M., Harbott, J., Ludwig, W.D., Henze, G., Gadner, H., Odenwald, E. & Riehm, H. (2000b) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia, 14, 22052222.
  • Schrauder, A., Reiter, A., Gadner, H., Niethammer, D., Klingebiel, T., Kremens, B., Peters, C., Ebell, W., Zimmermann, M., Niggli, F., Ludwig, W.D., Riehm, H., Welte, K. & Schrappe, M. (2006) Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results form ALL-BFM 90 and 95. Journal of Clinical Oncology, 24, 57425749.
  • Seibel, N.L., Steinherz, P.G., Sather, H.N., Nachman, J.B., Delaat, C., Ettinger, L.J., Freyer, D.R., Mattano, Jr, L.A., Hastings, C.A., Rubin, C.M., Bertolone, K., Franklin, J.L., Heerema, N.A., Mitchell, T.L., Pyesmany, A.F., La, M.K., Edens, C. & Gaynon, P.S. (2008) Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood, 111, 25482555.
  • Smith, M., Arthur, D., Camitta, B., Carroll, A.J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E.L., Link, M., Murphy, S., Pui, C.H., Pullen, J., Reaman, G., Sallan, S.E., Sather, H., Shuster, J., Simon, R., Trigg, M., Tubergen, D., Uckun, F. & Ungerleider, R. (1996) Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology, 14, 1824.
  • Spiegler, B.J., Kennedy, K., Maze, R., Greenberg, M.L., Weitzman, S., Hitzler, J.K. & Nathan, P.C. (2006) Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. Journal of Clinical Oncology, 24, 38583864.
  • Stark, B., Sharon, R., Rechavi, G., Attias, D., Ballin, A., Cividalli, G., Burstein, Y., Sthoeger, D., Abramov, A. & Zaizov, R. (2000) Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report. Cancer, 88, 205216.
  • Tubergen, D.G., Gilchrist, G.S., O’Brien, R.T., Coccia, P.F., Sather, H.N., Waskerwitz, M.J. & Hammond, G.D. (1993) Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Children’s Cancer Group report. Journal of Clinical Oncology, 11, 520526.
  • Uckun, F.M., Sensel, M.G., Sun, L., Steinherz, P.G., Trigg, M.E., Heerema, N.A., Sather, H.N., Reaman, G.H. & Gaynon, P.S. (1998) Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood, 91, 735746.
  • Vilmer, E., Suciu, S., Ferster, A., Bertrand, Y., Cavé, H., Thyss, A., Benoit, Y., Dastugue, N., Fournier, M., Souillet, G., Manel, A.M., Robert, A., Nelken, B., Millot, F., Lutz, P., Rialland, X., Mechinaud, F., Boutard, P., Behar, C., Chantraine, J.M., Plouvier, E., Laureys, G., Brock, P., Uyttebroeck, A., Margueritte, G., Plantaz, D., Norton, L., Francotte, N., Gyselinck, J., Waterkeyn, C., Solbu, G., Philippe, N. & Otten, J. (2000) Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia, 14, 22572266.
  • Waber, D.P., Turek, J., Catania, L., Stevenson, K., Robaey, P., Romero, I., Adams, H., Alyman, C., Jandet-Brunet, C., Neuberg, D.S., Sallan, S.E. & Silverman, L.B. (2007) Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. Journal of Clinical Oncology, 25, 49144921.
  • Winter, S.S., Holdsworth, M.T., Devidas, M., Raisch, D.W., Chauvenet, A., Ravindranath, Y., Ducore, J.M. & Amylon, M.D. (2006) Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG Study 9296. Pediatric Blood & Cancer, 46, 179186.
  • Winter, S.S., Jiang, Z., Khawaja, H.M., Griffin, T., Devidas, M., Asselin, B.L. & Larson, R.S., Children’s Oncology Group. (2007) Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood, 110, 14291438.